The Use of F-18-FDG PET/CT in Renal and Bladder Tumors
Journal Title: Nuclear Medicine Seminars - Year 2019, Vol 5, Issue 3
Abstract
Clinical imaging has been the cornerstone to guide patient management and therapy strategies for oncology patients. In the last decades, the use of fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) has been increased and PET/CT has been introduced as the major imaging technique in international guidelines for staging and re-staging of many cancer types as well as for assessment of therapy response in oncological imaging. In this review, the contribution of fluorodeoxyglucose PET/CT in renal and bladder tumors is discussed under current guidelines.
Authors and Affiliations
Burcu Esen Akkaş
The Management of Anti-thyroglobulin Antibody Elevation in the Follow-up of Patients with Differentiated Thyroid Cancer
The reliability of thyroglobulin (Tg) measurements in patients with differentiated thyroid cancer (DTC) decreases in anti-thyroglobulin antibody (TgAb) positivity. Although there is no definite judgment about the prognos...
Procedur Guideline for Lymphoscintigraphy and Sentinel Lymph Node in Breast Cancer
Sentinel lymph node (SLN) detection by lymphoscintigraphy (LS) and using intraoperative gamma probe is the mostly important prognostic factor in patients with breast cancer. Sentinel lymph node biopsy (SLNB) is a procedu...
Procedur Guideline for Prostate Cancer Imaging: Ga68 PSMA PET/CT
This guideline, mainly for nuclear medicine physicians contains recommendations in terms of procedure, reporting and interpretation in order to standardize Gallium-68 prostate specific membrane antigen (Ga-68 PSMA) posit...
Iodine-123 Meta-iodobenzylguanidine Cardiac Innervation Imaging Guideline
Sympathetic innervation of the heart plays an important role in the pathophysiology of diseases, especially congestive heart failure and arrhythmias. Iodine-123 metaiodobenzylguanidine (I-123 MIBG) scintigraphy allows fo...
Quality Control of Magistral (or in House or Smallscale) Produced Radiopharmaceuticals
As it is known, magistral radiopharmaceuticals are suitable for only in house use and are prepared, produced and supplied with a medical prescription for a certain patient in good laboratory practice (GLP) standard by a...